Home › NDC Lookup › Ingredients › Gabapentin › 72189-0158-30
GABAPENTIN 800 mg Tablet, Film Coated, 30-count — NDC 72189-0158-30 package photo

GABAPENTIN 800 mg Tablet, Film Coated, 30-count

by DIRECT RX · 30 TABLET, FILM COATED in 1 BOTTLE (72189-158-30)
NDC 72189-0158-30
🏷️ FDA NDC (as labeled) 72189-158-30 billing pads the product segment with a zero
This package
Contains30-count Pack sizes4 compare ↓
Also priced by: Part D plans $0.1402/unit — full pricing hub ↓
Also comes in: 60 tablets 72189-0158-60 90 tablets 72189-0158-90 120 tablets 72189-0158-72
Rx only Generic On market Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

⚠️
Other active recalls for Gabapentin (different manufacturers) — 6 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · Oct 10, 2025 — Failed Impurities/Degradation Specifications: an out of specification result obtained during routine stability testing for Highest Unknown Impurity . (The Harvard Drug Group LLC) · FDA recall D-0031-2026
Class II · Oct 10, 2025 — Failed Impurities/Degradation Specifications: an out of specification result obtained during routine stability testing for Highest Unknown Impurity . (The Harvard Drug Group LLC) · FDA recall D-0030-2026
Class II · Jun 19, 2025 — Defective container; blister packaging inadequately sealed. (The Harvard Drug Group LLC) · FDA recall D-0507-2025
Class II · Jun 19, 2025 — Defective container; blister packaging inadequately sealed. (The Harvard Drug Group LLC) · FDA recall D-0508-2025
Class II · Mar 13, 2025 — CGMP Deviations (Glenmark Pharmaceuticals Inc., USA) · FDA recall D-0320-2025
Class III · Mar 4, 2025 — Cross Contamination (SUN PHARMACEUTICAL INDUSTRIES INC) · FDA recall D-0312-2025
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗

🆔 Identity & classification

FDA NDC (as labeled) 72189-158-30
Product NDC 72189-158
11-digit billing NDC 72189015830
NCPDP billing unit EA — each (per item)
RxCUI 310430, 310432, 310434
UNII 6CW7F3G59X
Application # ANDA203244
SPL Set ID a7e45e3f-e382-32ba-e053-2a95a90a2537
Physiologic effect Decreased Central Nervous System Disorganized Electrical Activity
DEA schedule Non-controlled
Marketing category ANDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2020-12-01
Route ORAL
Dosage form TABLET, FILM COATED
Substance GABAPENTIN
GPI-14 72600030000340
GPI class Gabapentin
GCN Seq No 041806
GCN 94447
HICL code 008831
Ingredient (HICL) Gabapentin
HIC1 code H
Therapeutic class — broad (HIC1) Nervous System (Except Autonomic)
HIC2 code H4
Therapeutic class — intermediate (HIC2) Anticonvulsants
HIC3 code H4B
Therapeutic class — specific (HIC3) Anticonvulsants
AHFS code 28:08.92.00
AHFS class Analgesics And Antipyretics, Misc.
FDB label name GABAPENTIN 800 MG TABLET
FDB brand name Gabapentin
Legend status F — Federal legend — prescription drug or device
TE code (Orange Book) AB1 · RLD · RS
Why two NDCs? The FDA registers this code as 72189-158-30 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 72189-0158-30. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏷️ RxNorm drug class

This medicine belongs to the Gabapentinoids class.

Drug family (ATC) Gabapentinoids
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

🏭 Manufacturer & labeler

LabelerDIRECT RX
Application holderSTRIDES PHARMA GLOBAL PTE LTD
FDA applicationANDA203244 (ANDA)
Labeler code72189
First marketedDec 2020
Product typeHuman Prescription Drug
Portfolio204 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

Label name GABAPENTIN 800 MG TABLET Ingredient Gabapentin
📖 What it is MedlinePlus · NLM

Gabapentin capsules, tablets, and oral solution are used along with other medications to help control certain types of seizures in people who have epilepsy. Gabapentin capsules, tablets, and oral solution are also used to relieve the pain of postherpetic neuralgia (PHN; the burning, stabbing pain or aches that may last for months or years after an attack of shingles). Gabapentin extended-release tablets (Horizant) are used to treat restless legs syndrome (RLS; a condition that causes discomfort in the legs and a strong urge to move the legs, especially at night and when sitting or lying down)....

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • Gabapentin is mainly used for two things: managing nerve pain that lingers after a shingles infection (called postherpetic neuralgia) in adults, and helping control partial onset s...
  • This is a really important question. Taking gabapentin together with opioids like morphine, hydrocodone, or oxycodone significantly raises the risk of serious breathing problems —...
  • Can I take gabapentin with my opioid pain medication?
  • The most common ones — especially in the first few weeks — are dizziness, drowsiness, and sometimes loss of balance or coordination. Swelling in the feet or hands is also fairly co...
📖 Read our full Gabapentin guide →
1
Nutrient depletion considerations

Gabapentin may be associated with lower levels of 1 nutrient — worth a chat with your pharmacist, not a cause for alarm.

🧪 Full Gabapentin nutrient depletion report →
An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

💊 What it looks like

Color white / orange
ShapeCapsule
ImprintSG;178
Size19 mm
ScoringScored — splits in 2
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII D9C330MD8B
    Copovidone is a synthetic polymer made by combining two types of plastic-like molecules. It acts as a binder and film-former to help hold tablet ingredients together and improve how the medicine dissolves in your body.
  • UNII 2165RE0K14
    A plant-based thickener made from cellulose that helps control how quickly the medicine dissolves and releases its active ingredient. It also binds ingredients together and improves the tablet's texture and handling during manufacturing.
  • UNII 9XZ8H6N6OH
    A plant-based cellulose derivative used as a binder to hold tablet ingredients together, a thickener in liquids, and a coating agent to control how fast the medicine dissolves.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII 3OWL53L36A
    A natural sugar alcohol derived from seaweed or synthesized in the lab. It's used as a filler to add bulk, a sweetener in sugar-free formulas, and a disintegrant to help tablets break apart in the stomach.
  • UNII TUF2IVW3M2
    Poloxamer 407 is a synthetic polymer made from ethylene oxide and propylene oxide. In medicines, it acts as a thickener, emulsifier, and solubilizer to help mix ingredients and create the right texture.
  • UNII 3WJQ0SDW1A
    Polyethylene glycol is a synthetic liquid or solid polymer used in medicines as a solvent, lubricant, and humectant. It helps dissolve active ingredients, reduces friction during manufacturing, and retains moisture in the final product.
  • UNII 532B59J990
    Polyvinyl alcohol is a synthetic polymer made from plant-derived materials. It's used as a binder to hold ingredients together, a film-former in coatings, and a thickener in liquid formulations.
  • UNII 7SEV7J4R1U
    A powder made from a naturally occurring mineral. In medicines, talc works as a glidant and anti-caking agent, helping tablets and capsules flow smoothly during manufacturing and preventing clumping.
  • UNII 15FIX9V2JP
    Titanium dioxide is a bright white mineral powder commonly used as a colorant and opacifying agent. It makes pills and tablets white or lighter in color and helps make coatings non-transparent.

10 inactive ingredients listed in the exact product block matched to this NDC.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · Q2 2026 $0.1402 $4.21 / 30 tablets
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Gabapentin 800 mg 00904-7108-61 Major 1 tablet $0.090 AB1 Availability likely —
Gabapentin 800 mg 16571-0117-01 Rising 100 tablets $0.090 AB1 Availability likely —
Gabapentin 800 mg 16714-0332-01 NorthStar 100 tablets $0.090 AB1 Availability likely —
Gabapentin 800 mg 31722-0167-01 Camber 100 tablets $0.090 AB1 Availability likely —
Gabapentin 800 mg 50228-0178-01 ScieGen 100 tablets $0.090 AB1 Availability likely —
Gabapentin 800 mg 50268-0326-13 AvPAK 1 tablet $0.090 AB1 Discontinued —
Gabapentin 800 mg 60687-0518-01 American 1 tablet $0.090 AB1 Availability likely —
Gabapentin 800 mg 64380-0728-01 Strides 100 tablets $0.090 AB1 Availability likely —
Gabapentin 800 mg 65862-0524-01 Aurobindo 100 tablets $0.090 AB1 Availability likely —
Gabapentin 800 mg 67877-0429-01 Ascend 100 tablets $0.090 AB1 Availability likely —
Gabapentin 800 mg 68001-0412-00 BluePoint 100 tablets $0.090 AB1 Availability likely —
Gabapentin 800 mg 68094-0489-50 Precision 100 tablets $0.090 AB1 Availability likely —
Gabapentin 800 mg 68382-0205-01 Zydus 100 tablets $0.090 AB1 Availability likely —
Gabapentin 800 mg 68462-0127-01 Glenmark 100 tablets $0.090 AB1 Availability likely —
Gabapentin 800 mg 69367-0347-05 Westminster 500 tablets $0.090 AB1 Availability likely —
Gabapentin 800 mg 70010-0228-01 Granules 100 tablets $0.090 AB1 Availability likely —
Gabapentin 800 mg 76282-0406-01 Exelan 100 tablets $0.090 — Availability likely —
Gabapentin 800 mg 76282-0707-05 Exelan 500 tablets $0.090 AB1 Availability likely —
Gabapentin 800 mg 82009-0072-05 QUALLENT 500 tablets $0.090 AB1 Availability likely —
Gabapentin 800 mg 83301-0002-01 Mullan 100 tablets $0.090 AB1 Availability likely —
Gabapentin 800 mg 71093-0112-04 ACI 100 tablets $0.098 AB1 Availability likely —
gabapentin 800 mg 62756-0204-01 Sun 100 tablets $0.098 — FDA listed —
Gabapentin 800 mg 51224-0121-50 TAGI 100 tablets $0.124 AB1 Discontinued —
Neurontin 800 mg 00071-0401-24 Parke-Davis 100 tablets $16.978 AB1 Discontinued —
Neurontin 800 mg 58151-0285-01 Viatris 100 tablets $16.978 AB1 Availability likely —
Gabapentin 800 mg 42385-0980-01 Laurus 100 tablets — AB1 FDA listed —
Gabapentin 800 mg 43063-0611-90 PD-Rx 90 tablets — AB1 FDA listed —
Gabapentin 800 mg 50090-6189-00 A-S 60 tablets — AB1 FDA listed —
Gabapentin 800 mg 50090-7400-00 A-S 60 tablets — AB1 FDA listed —
Gabapentin 800 mg 55154-3366-00 Cardinal 1 tablet — AB1 FDA listed —
Gabapentin 800 mg 55154-8193-00 Cardinal 1 tablet — AB1 FDA listed —
Gabapentin 800 mg 58118-1167-08 Clinical 30 tablets — AB1 FDA listed —
Gabapentin 800 mg 60760-0517-60 St. 60 tablets — AB1 Discontinued —
Gabapentin 800 mg 60760-0837-60 ST. 60 tablets — AB1 FDA listed —
Gabapentin 800 mg 63187-0010-30 Proficient 30 tablets — AB1 FDA listed —
Gabapentin 800 mg 63187-0148-90 Proficient 90 tablets — AB1 FDA listed —
Gabapentin 800 mg 63629-7308-01 Bryant 90 tablets — AB1 Discontinued —
Gabapentin 800 mg 63629-8489-01 Bryant 500 tablets — AB1 FDA listed —
Gabapentin 800 mg 63629-8490-01 Bryant 100 tablets — AB1 FDA listed —
Gabapentin 800 mg 65841-0706-01 Zydus 100 tablets — AB1 FDA listed —
Gabapentin 800 mg 67046-1536-03 Coupler 30 tablets — AB1 FDA listed —
Gabapentin 800 mg 67046-1667-03 Coupler 30 tablets — AB1 FDA listed —
Gabapentin 800 mg 68071-2206-01 NuCare 100 tablets — AB1 FDA listed —
Gabapentin 800 mg 68071-2214-09 NuCare 90 tablets — AB1 FDA listed —
Gabapentin 800 mg 68071-3523-09 NuCare 90 tablets — AB1 FDA listed —
Gabapentin 800 mg 68788-7757-01 Preferred 100 tablets — AB1 FDA listed —
Gabapentin 800 mg 68788-7774-01 Preferred 100 tablets — AB1 FDA listed —
Gabapentin 800 mg 68788-8468-01 Preferred 100 tablets — AB1 FDA listed —
Gabapentin 800 mg 68788-8790-01 Preferred 100 tablets — AB1 FDA listed —
Gabapentin 800 mg 69097-0811-02 Cipla 30 tablets — — FDA listed —
Gabapentin 800 mg 70518-2323-00 REMEDYREPACK 30 tablets — AB1 FDA listed —
Gabapentin 800 mg 70518-2912-00 REMEDYREPACK 100 tablets — AB1 Discontinued —
Gabapentin 800 mg 71205-0160-30 Proficient 30 tablets — AB1 FDA listed —
Gabapentin 800 mg 71205-0514-30 Proficient 30 tablets — AB1 FDA listed —
Gabapentin 800 mg 71205-0774-30 Proficient 30 tablets — AB1 FDA listed —
Gabapentin 800 mg 71205-0932-00 Proficient 100 tablets — AB1 FDA listed —
Gabapentin 800 mg 71335-0254-01 Bryant 30 tablets — AB1 FDA listed —
Gabapentin 800 mg 71335-1007-01 Bryant 30 tablets — AB1 FDA listed —
Gabapentin 800 mg 71335-1041-01 Bryant 90 tablets — AB1 FDA listed —
Gabapentin 800 mg 71335-2037-01 Bryant 30 tablets — AB1 FDA listed —
Gabapentin 800 mg 71335-2038-01 Bryant 90 tablets — AB1 FDA listed —
Gabapentin 800 mg 71335-2765-01 Bryant 30 tablets — AB1 FDA listed —
Gabapentin 800 mg 71335-2819-01 Bryant 90 tablets — AB1 FDA listed —
Gabapentin 800 mg 71335-3057-01 Bryant 30 tablets — AB1 FDA listed —
Gabapentin 800 mg 71610-0426-60 Aphena 90 tablets — AB1 FDA listed —
Gabapentin 800 mg 71610-0630-30 Aphena 30 tablets — AB1 FDA listed —
Gabapentin 800 mg 71610-0737-30 Aphena 30 tablets — AB1 FDA listed —
Gabapentin 800 mg 71610-0778-45 Aphena 45 tablets — AB1 FDA listed —
Gabapentin 800 mg 72162-1531-01 Bryant 100 tablets — AB1 FDA listed —
Gabapentin 800 mg 72162-2142-01 Bryant 100 tablets — AB1 FDA listed —
Gabapentin 800 mg 72189-0092-90 DIRECT 90 tablets — AB1 FDA listed —
Gabapentin 800 mgthis 72189-0158-30 DIRECT 30 tablets — AB1 FDA listed —
Gabapentin 800 mg 72189-0178-30 DIRECT 30 tablets — AB1 FDA listed —
Gabapentin 800 mg 72189-0394-72 Direct_Rx 120 tablets — AB1 FDA listed —
Gabapentin 800 mg 72189-0619-72 Direct_Rx 120 tablets — AB1 FDA listed —
Gabapentin 800 mg 72789-0217-60 PD-Rx 60 tablets — AB1 FDA listed —
Gabapentin 800 mg 72865-0256-05 XLCare 500 tablets — AB1 FDA listed —
Gabapentin 800 mg 72888-0132-00 Advagen 1000 tablets — AB1 FDA listed —
Gabapentin 800 mg 76420-0497-01 Asclemed 100 tablets — AB1 FDA listed —
Gabapentin 800 mg 76420-0837-01 Asclemed 100 tablets — AB1 FDA listed —
Gabapentin 800 mg 77771-0178-05 Radha 500 tablets — AB1 FDA listed —
Gabapentin 800 mg 80425-0035-01 Advanced 30 tablets — AB1 FDA listed —
Gabapentin 800 mg 80425-0036-01 Advanced 30 tablets — AB1 FDA listed —
Gabapentin 800 mg 80425-0158-01 Advanced 30 tablets — AB1 FDA listed —
Gabapentin 800 mg 80425-0204-01 Advanced 30 tablets — AB1 FDA listed —
Gabapentin 800 mg 82619-0146-01 Creekwood 100 tablets — AB1 FDA listed —
Gabapentin 800 mg 82804-0203-30 Proficient 30 tablets — AB1 FDA listed —
Gabapentin 800 mg 82804-0249-90 Proficient 90 tablets — AB1 FDA listed —
Gabapentin 800 mg 85534-0010-00 HAWAII 30 tablets — AB1 FDA listed —
Gabapentin 800 mg 71335-1601-01 Bryant 30 tablets — AB1 FDA listed —
Gabapentin 800 mg 68071-5310-09 NuCare 90 tablets — AB1 FDA listed —
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

⏳ Availability & generic status

🏛️
2020
On the market since
Dec 2020
📍
2026
Currently FDA-listed
6 years listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

📊 Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Gabapentin — the program that covers self-administered drugs. 41 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Gabapentin. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$151.2M
Claims incl. refills
8.9M
Beneficiaries
5.1M
Spend / beneficiary
$29.73
Spend / claim
$16.90
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

🔬 Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Gabapentin — the ingredient across all brands.

Top reported reactions

Fatigue24,972
Nausea22,728
Pain21,181
Diarrhoea18,114
Headache17,897
Dizziness16,238
Fall15,536

Reporter sex

361,481 reports
Male · 35%
Female · 65%
Unknown · 0%

Serious outcomes

Life-threatening10,681
Disabling9,725
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 32,285 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

📦 Packaging — all sizes for this product

Package NDCDescription Marketing startStatus
72189-0158-30 You're viewing this 30 TABLET, FILM COATED in 1 BOTTLE (72189-158-30) 2020-12-01 Active
72189-0158-60 60 TABLET, FILM COATED in 1 BOTTLE (72189-158-60) 2020-12-01 Active
72189-0158-72 120 TABLET, FILM COATED in 1 BOTTLE (72189-158-72) 2020-12-01 Active
72189-0158-90 90 TABLET, FILM COATED in 1 BOTTLE (72189-158-90) 2020-12-01 Active

You're viewing the smallest of 4 pack sizes for this product.

Pack size FAQ

What quantity is in NDC 72189-0158-30?
NDC 72189-0158-30 is a 30-count package — 30 tablet, film coated in 1 bottle.
What is the difference between NDC 72189-0158-30 and NDC 72189-0158-60?
Both are GABAPENTIN 800 mg Tablet, Film Coated — the drug itself is identical. NDC 72189-0158-30 is the 30-count package, while NDC 72189-0158-60 is the 60 tablets package.
What NDC number is used to bill for this package of GABAPENTIN 800 mg Tablet, Film Coated?
Bill NDC 72189-0158-30 — the 11-digit billing format is 72189015830. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

🧭 About this NDC listing & data coverage

Finished prescription product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data ✓ Available
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 72189-158-30, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 72189-0158-30, written without dashes as 72189015830. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 72189-0158-30, the first segment (72189) is the labeler code FDA assigned to DIRECT RX; the middle segment (0158) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (30) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by DIRECT RX. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 3 other package presentations of this same product, including 60 tablets (72189-0158-60), 90 tablets (72189-0158-90), 120 tablets (72189-0158-72). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
DIRECT RX is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as a prescription product, so it is dispensed under a prescriber's order. Your pharmacist can tell you whether any over-the-counter forms of the same medication exist.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.

📄 Full prescribing information FDA SPL

The complete FDA label for this product — the official prescribing information, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🆘 Overdosage 📦 How Supplied / Storage and Handling 💬 Medication Guide
🆘 Overdosage 1 words ▾

72189-158-30

📦 How Supplied / Storage and Handling 29 words ▾

100 mg Capsules (White/White colored, size '3' hard gelatin capsules with "103" printed on body of capsules containing white to off white granular powder) Bottles of 100 & 500

💬 Medication Guide ~3 min read ▾

Gabapentin (gab'' a pen' tin)Capsules What is the most important information I should know about gabapentin capsules? Do not stop taking gabapentin capsules without first talking to your healthcare provider. Stopping gabapentin capsules suddenly can cause serious problems.

Gabapentin capsules can cause serious side effects including: 1. Suicidal Thoughts. Like other antiepileptic drugs, gabapentin capsules may cause suicidal thoughts or actions in a very small number of people, about 1 in 500.

Call a healthcare provider right away if you have any of these symptoms, especially if they are new, worse, or worry you: · thoughts about suicide or dying · attempts to commit suicide · new or worse depression · new or worse anxiety · feeling agitated or restless · panic attacks · trouble sleeping (insomnia) · new or worse irritability · acting aggressive, being angry, or violent · acting on dangerous impulses · an extreme increase in activity and talking (mania) · other unusual changes in behavior or mood How can I watch for early symptoms of suicidal thoughts and actions? · Pay attention to any changes, especially sudden changes, in mood, behaviors, thoughts, or feelings. · Keep all follow-up visits with your healthcare provider as scheduled.

Call your healthcare provider between visits as needed, especially if you are worried about symptoms. Do not stop taking gabapentin capsules without first talking to a healthcare provider. · Stopping gabapentin capsules suddenly can cause serious problems. Stopping a seizure medicine suddenly in a patient who has epilepsy can cause seizures that will not stop (status epilepticus). · Suicidal thoughts or actions can be caused by things other than medicines.

If you have suicidal thoughts or actions, your healthcare provider may check for other causes. 2. Changes in behavior and thinking -Using gabapentin capsules in children 3 to 12 years of age can cause emotional changes, aggressive behavior, problems with concentration, restlessness, changes in school performance, and hyperactivity.

3. Gabapentin capsules may cause a serious or life-threatening allergic reaction that may affect your skin or other parts of your body such as your liver or blood cells. This may cause you to be hospitalized or to stop gabapentin capsule.

You may or may not have a rash with an allergic reaction caused by gabapentin capsule. Call a healthcare provider right away if you have any of The following symptoms: · skin rash · hives · difficulty breathing · fever · swollen glands that do not go away · swelling of your face, lips, throat or tongue · yellowing of your skin or of the whites of the eyes · unusual bruising or bleeding · severe fatigue or weakness · unexpected muscle pain · frequent infections These symptoms may be the first signs of a serious reaction.

A healthcare provider should examine you to decide if you should continue taking gabapentin capsules. What are gabapentin capsules? Gabapentin capsules are a prescription medicine used to treat: · Pain from damaged nerves (postherpetic pain) that follows healing of shingles (a painful rash that comes after a herpes zoster infection) in adults. · Partial seizures when taken together with other medicines in adults and children 3 years of age and older with seizures.

Who should not take gabapentin capsules? Do not take gabapentin capsules if you are allergic to gabapentin or any of the other ingredients in gabapentin capsules. See the end of this Medication Guide for a complete list of ingredients in gabapentin capsules.

What should I tell my healthcare provider before taking gabapentin capsules? Before taking gabapentin capsules, tell your healthcare provider if you: · have or have had kidney problems or are on hemodialysis · have or have had depression, mood problems, or suicidal thoughts or behavior · have diabetes · are pregnant or plan to become pregnant. It is not known if gabapentin capsules can harm your unborn baby.

Tell your healthcare provider right away if y…

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
← 72189-0157-30 · direct 72189-0159-30 · DIRECT →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.